NasdaqGS:IONSBiotechs
Ionis Pharmaceuticals (IONS) Stock Slips As Revenue Drops And Losses Return
Ionis Pharmaceuticals stock slipped about 1.4% today and sits near US$53 after a tough few months that left shares down roughly one third over 30 and 90 days. The price reaction looks modest next to the earnings headline. Ionis delivered Q2 revenue of US$268m and highlighted a cash balance of US$2.1b, which gives the company room to keep funding its pipeline.
Short term traders are focused on the ongoing loss per share in this quarter. Longer term investors are weighing that against full year...